Head to Head Analysis: Medican Enterprises (OTCMKTS:MDCN) and Newmark Group (NASDAQ:NMRK)

Newmark Group (NASDAQ:NMRK) and Medican Enterprises (OTCMKTS:MDCN) are both real estate companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Newmark Group and Medican Enterprises, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Newmark Group	0	0	3	0	3.00
Medican Enterprises	0	0	0	0	N/A

Newmark Group presently has a consensus target price of $16.17, indicating a potential upside of 10.81%.

Institutional and Insider Ownership

58.4% of Newmark Group shares are owned by institutional investors. 31.8% of Newmark Group shares are owned by insiders. Comparatively, 2.9% of Medican Enterprises shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Newmark Group and Medican Enterprises’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Newmark Group	1.75%	17.78%	6.05%
Medican Enterprises	N/A	N/A	N/A

Earnings & Valuation

This table compares Newmark Group and Medican Enterprises”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Newmark Group	$2.54 billion	0.99	$42.58 million	$0.22	66.32
Medican Enterprises	N/A	N/A	N/A	($1.34)	N/A

Newmark Group has higher revenue and earnings than Medican Enterprises. Medican Enterprises is trading at a lower price-to-earnings ratio than Newmark Group, indicating that it is currently the more affordable of the two stocks.

Summary

Newmark Group beats Medican Enterprises on 9 of the 9 factors compared between the two stocks.

About Newmark Group

Newmark Group, Inc. provides commercial real estate services in the United States, the United Kingdom, and internationally. The company offers capital markets consisting of investment sales and commercial mortgage brokerage; landlord or agency representation leasing; valuation and advisory; property management; commercial real estate technology platform and capabilities; the United Kingdom business rates services; due diligence, consulting, and other advisory services; GSEs and the Federal Housing Administration lending services comprising multifamily lending and loan servicing; asset management; and flexible workspace solutions for owners. It also provides tenant representation leasing; and global corporate services consisting of workplace and occupancy strategy, energy and sustainability services, technology, project management, real estate and lease administration, and facilities management. The company offers its services to commercial real estate tenants, investors, owners, occupiers, and developers; lenders; small and medium size businesses; and multi-national corporations. The company was formerly known as Newmark Grubb Knight Frank Capital Group and changed its name to Newmark Group, Inc. in October 2017. Newmark Group, Inc. was founded in 1929 and is based in New York, New York. Newmark Group, Inc.operates is a subsidiary of Cantor Fitzgerald, L.P.

About Medican Enterprises

Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.